Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-(3-Methoxyphenoxy)propionic acid is a chemical compound characterized by the molecular formula C12H14O4. It is a white to off-white powder with slight solubility in water. This versatile compound serves as a building block in the synthesis of pharmaceuticals and agrochemicals, and is recognized for its anti-inflammatory properties. It is marketed as a nonsteroidal anti-inflammatory drug (NSAID) under its own name, and is known to inhibit cyclooxygenase activity, thereby reducing the production of prostaglandins, which are key mediators of inflammation.

49855-03-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 49855-03-0 Structure
  • Basic information

    1. Product Name: 3-(3-METHOXYPHENOXY)PROPIONIC ACID
    2. Synonyms: 3-(3-METHOXYPHENOXY)PROPIONIC ACID;BUTTPARK 80\07-09;3'-Methoxy-3-phenoxypropanoic acid
    3. CAS NO:49855-03-0
    4. Molecular Formula: C10H12O4
    5. Molecular Weight: 196.2
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 49855-03-0.mol
  • Chemical Properties

    1. Melting Point: 83 °C
    2. Boiling Point: 319.8°C at 760 mmHg
    3. Flash Point: 124.7°C
    4. Appearance: /
    5. Density: 1.188g/cm3
    6. Vapor Pressure: 0.000138mmHg at 25°C
    7. Refractive Index: 1.523
    8. Storage Temp.: Sealed in dry,Room Temperature
    9. Solubility: soluble in Methanol
    10. PKA: 4.21±0.10(Predicted)
    11. CAS DataBase Reference: 3-(3-METHOXYPHENOXY)PROPIONIC ACID(CAS DataBase Reference)
    12. NIST Chemistry Reference: 3-(3-METHOXYPHENOXY)PROPIONIC ACID(49855-03-0)
    13. EPA Substance Registry System: 3-(3-METHOXYPHENOXY)PROPIONIC ACID(49855-03-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 49855-03-0(Hazardous Substances Data)

49855-03-0 Usage

Uses

Used in Pharmaceutical Industry:
3-(3-Methoxyphenoxy)propionic acid is used as an active pharmaceutical ingredient for its anti-inflammatory properties, serving as a nonsteroidal anti-inflammatory drug (NSAID). It is utilized for its ability to inhibit the activity of cyclooxygenase, an enzyme involved in the production of prostaglandins, which are mediators of inflammation, thus providing relief from inflammation and pain.
Used in Agrochemical Industry:
3-(3-Methoxyphenoxy)propionic acid is used as a key component in the production of herbicides and pesticides. Its versatile chemical structure allows for the development of effective compounds that can control or kill unwanted plants and pests, contributing to improved crop yields and agricultural management.
These applications highlight the compound's significance in both the healthcare and agricultural sectors, underscoring its multifaceted utility in addressing inflammation and enhancing crop protection.

Check Digit Verification of cas no

The CAS Registry Mumber 49855-03-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,9,8,5 and 5 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 49855-03:
(7*4)+(6*9)+(5*8)+(4*5)+(3*5)+(2*0)+(1*3)=160
160 % 10 = 0
So 49855-03-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H12O4/c1-13-8-3-2-4-9(7-8)14-6-5-10(11)12/h2-4,7H,5-6H2,1H3,(H,11,12)

49855-03-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(3-Methoxyphenoxy)propionic Acid

1.2 Other means of identification

Product number -
Other names 3-(3-methoxyphenoxy)propanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:49855-03-0 SDS

49855-03-0Relevant articles and documents

Facile access to chiral 4-substituted chromanes through Rh-catalyzed asymmetric hydrogenation

Tao, Lin,Zhao, Qingyang,Zhang, Xumu,Dong, Xiu-Qin

, p. 1859 - 1862 (2020/01/21)

Rh/ZhaoPhos-catalyzed asymmetric hydrogenation of a series of (E)-2-(chroman-4-ylidene)acetates was successfully developed to prepare various chiral 4-substituted chromanes with high yields and excellent enantioselectivities (up to 99percent yield, 98percent ee). Moreover, the gram-scale hydrogenation could be performed well in the presence of 0.02 molpercent catalyst loading (TON = 5000), the hydrogenation product was easily converted to access other important compounds, which demonstrated the synthetic utility of this asymmetric catalytic methodology.

Copper(ii)-catalyzed C-O coupling of aryl bromides with aliphatic diols: Synthesis of ethers, phenols, and benzo-fused cyclic ethers

Liu, Yajun,Park, Se Kyung,Xiao, Yan,Chae, Junghyun

, p. 4747 - 4753 (2014/06/24)

A highly efficient copper-catalyzed C-O cross-coupling reaction between aryl bromides and aliphatic diols has been developed employing a cheaper, more efficient, and easily removable copper(ii) catalyst. A broad range of aryl bromides were coupled with aliphatic diols of different lengths using 5 mol% CuCl2 and 3 equivalents of K2CO3 in the absence of any other ligands or solvents to afford the corresponding hydroxyalkyl aryl ethers in good to excellent yields. In this newly developed protocol, aliphatic diols have multilateral functions as coupling reactants, ligands, and solvents. The resulting hydroxyalkyl aryl ethers were further readily converted into the corresponding phenols, presenting a valuable alternative way to phenols from aryl bromides. Furthermore, it was demonstrated that they are useful intermediates for more advanced molecules such as benzofurans and benzo-fused cyclic ethers. This journal is

Anti-inflammatory activities of selected synthetic homoisoflavanones

Shaikh, Mahidansha M.,Kruger, Hendrik G.,Bodenstein, Johannes,Smith, Peter,Du Toit, Karen

experimental part, p. 1473 - 1482 (2012/09/22)

Four homoisoflavanones of the 3-benzylidene-4-chromanone type, some of which were previously isolated from Caesalpinia pulcherrima, were synthesised to determine their anti-inflammatory activity and cytotoxicity. A range of four different homoisoflavanones (compounds 4a-4d) were synthesised from the corresponding substituted phenols.1H-and 13C-NMR data together with high-resolution mass spectroscopy data were employed to elucidate the structures. Anti-inflammatory activity was determined in mice with acute croton oil-induced auricular dermatitis. Invitro cytotoxicity was tested against a Chinese hamster ovarian cell line using the 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazoliumbromide (MTT) assay. Compound 4a exhibited a tendency to inhibit oedema in a dose-dependent manner after 3 and 6 h of treatment. Compounds 4b-4d also inhibited oedema, although a clear dose-response relationship was not observed. Compounds 4a-4c were found to be less cytotoxic than compound 4d. Compound 4b was the least cytotoxic. Compounds 4a-4d exhibited anti-inflammatory activity and varying levels of cytotoxicity.

(1,4-DIAZA-BICYCLO[3.2.2]NON-6-EN-4-YL)-HETEROCYCLYL-METHANONE LIGANDS FOR NICOTINIC ACETYLCHOLINE RECEPTORS, USEFUL FOR THE TREATMENT OF DISEASE

-

Page/Page column 59; 60, (2009/05/30)

The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nACh receptors), activation of nACh receptors, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds, which act as ligands for the a7 nACh receptor subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof. The novel compounds include compounds of formula I: (I) wherein X, R1, and R2 are as herein defined.

Chemoenzymatic synthesis and resolution of compounds containing a quaternary stereocenters adjacent to a carbonyl group

Mahapatra, Tridib,Jana, Nandan,Nanda

, p. 1224 - 1232 (2008/09/21)

Racemic compounds containing a quaternary stereocenter (having hydroxymethyl and alkyl group adjacent to keto functionality) based on chromanone, α-tetralone, and indalone scaffolds have been synthesized. An enzymatic irreversible transesterification approach has been applied to generate the pure enantiomers in a stereocontrolled fashion. The pure enantiomers of some α,α-dialkylated carbonyl compounds have been synthesized by this method.

Enantioselective enzymatic desymmetrization of prochiral 1,3-diols and enzymatic resolution of monoprotected 1,3-diols based on α-tetralone and related multifunctional scaffolds

Mahapatra, Tridib,Das, Tapas,Nanda, Samik

body text, p. 2497 - 2507 (2009/04/11)

Novel multifunctional chemotypes based on α-tetralone, α-indanone, and chromanone have been synthesized by a chemo-enzymatic approach by applying an enzymatic irreversible transesterification strategy. The scaffolds synthesized can be further elaborated with subsequent enzymatic as well as chemical transformations for the generation of new sets of structurally related organic molecules.

ERβ ligands. Part 6: 6H-Chromeno[4,3-b]quinolines as a new series of estrogen receptor β-selective ligands

Vu, An T.,Campbell, Alison N.,Harris, Heather A.,Unwalla, Rayomand J.,Manas, Eric S.,Mewshaw, Richard E.

, p. 4053 - 4056 (2008/02/08)

A new class of estrogen receptor beta (ERβ) ligands based on the 6H-chromeno[4,3-b]quinoline scaffold has been prepared. Several C7-substituted analogues displayed high affinity and modest selectivity for ERβ.

6H-[1]benzopyrano[4,3-b]quinolines and their use as estrogenic agents

-

Page/Page column 7; 10, (2010/10/20)

This invention provides 6H-[1]benzopyrano[4,3-b]quinoline compounds having the formula I: The invention further provides compositions including the compounds, methods for the use of the compounds, and methods of preparation of the compounds.

Synthesis, stereochemical assignments, and biological activities of homoisoflavonoids

Siddaiah, Vidavalur,Rao, Chunduri Venkata,Venkateswarlu, Somepalli,Krishnaraju, Alluri V.,Subbaraju, Gottumukkala V.

, p. 2545 - 2551 (2007/10/03)

A series of four naturally occurring homoisoflavonoids and eight analogs have been synthesized starting from an appropriately substituted phenol through chroman-4-one, in four steps. The products were assigned as E-isomers based on NMR spectroscopic data.

Synthesis of 3-(p-Halobenzyl)-4-aryl-2H-chromenes as Selective Ligands for Antiestrogen-binding Sites.

Srikanth, Natarajan,Kon, Oi-Lian,Ng, Siu-Choon,Sim, Keng-Yeow

, p. 1412 - 1422 (2007/10/03)

A series of basic ethers of 3-(p-halobenzyl)-4-aryl-2H-chromenes was synthesised from a common precursor, the corresponding 3-benzylidenechromanones (homoisoflavanones), by two routes.The three-step first route involves the reduction of the 3-benzylidenec

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 49855-03-0